These shares recommend experts for selling
In the last week of trade, the stock market world was shaken by a wave of sales recommendations. Numerous analysts and experts advise to repeal shares and rely on safer systems. You can find out which share certificates you have specifically recommended for sale here.
– on your own behalf –
Tip: Act your shares now for € 0.00 At finanzen.net zero! Inform here
16th place: the ranking
Investors who want to buy or sell shares often consult analysts. In the past trade week, numerous experts have once again gained the exit from shares. These shares were recommended for sale by the analysts.
Source: finanzen.net, Image: Maxx-Studio / Shutterstock.com
15th place: Pernod Ricard
The British investment bank Barclays has raised the price target for Pernod Ricard from 90 to 94 euros, but left the classification on “Underweight”. For analysis
Source: finanzen.net, Image: Gil C / Shutterstock.com
14th place: BASF
The US bank JPmorgan left the classification for BASF on “Underweight”. For analysis
Source: finanzen.net, Image: Press photo BASF
13th place: Evonik
The Jefferies analysis house left Evonik on “Under Perperform”. For analysis
Source: finanzen.net, Image: Jonathan Weiss / Shutterstock.com
12th place: rational
Baader Bank left the classification for rationally before numbers on “Reduce” with a price target of 720 euros. For analysis
Source: finanzen.net, picture: rational
11th place: Intel
The US bank JPmorgan left the classification for Intel with a view of a majority sale of the daughter Altera on “Underweight” with a price target of $ 23. For analysis
Source: finanzen.net, picture: lyao / shutterstock.com
10th place: Beiersdorf
The major Swiss bank UBS left Beiersdorf on “Sell” after quarterly sales figures with a price target of 117 euros. For analysis
Source: finanzen.net, Image: Beiersdorf
9th place: Carl Zeiss Meditec
The US bank JPmorgan left Carl Zeiss Meditec on “Underweight” with a price target of 41 euros after preliminary quarterly figures. For analysis
Source: finanzen.net, Image: Carl Zeiss Meditec
8th place: Docmorris
The Baader Bank has graduated from “Add” to “Reduce” and reduced the price target from 44 to CHF 19. For analysis
Source: finanzen.net, Image: Ralf Liebhold / Shutterstock.com
7th place: Yara
The Jefferies analysis house left the classification for Yara on “Under Perperform”. For analysis
Source: finanzen.net, Image: Sebastian Braum / Yara
6th place: Puma
The major Swiss bank UBS has reduced the price target for Puma from 19.50 to 19.00 euros and left the classification to “Sell”. For analysis
Source: finanzen.net, Image: Robert Ascroft/ Puma
5th place: Ericsson
The US investment bank Goldman Sachs has lowered the price target for Ericsson from 62 to 58 Swedish crowns and left the classification on “Sell”. For analysis
Source: finanzen.net, Image: Jari J / Shutterstock.com
4th place: Fig
The US analysis house Bernstein Research left the classification for ABB after quarterly figures on “Under Perperform” with a price target of CHF 45. For analysis
Source: finanzen.net, Image: Fig
3rd place: FMC
The US bank JPmorgan left the classification for FMC with a price target of 41.50 euros to “Underweight”. For analysis
Source: finanzen.net, Image: Fresenius Medical Care
2nd place: Siemens Energy
The major Swiss bank UBS left the classification for Siemens Energy for the second business quarter and a forecast increase on “Sell” with a price target of 38 euros. For analysis
Source: finanzen.net, Image: Siemens Energy AG
1st place: Nordea
The US bank JPmorgan left the classification for Nordea at the price target of 140 Swedish crowns on “Underweight”. For analysis
Source: finanzen.net, Image: Vytauta’s Kielaitis / Shutterstock.com
More news
Image sources: Ilkin Zeferli / Shutterstock.com, Victor Moussa / Shutterstock.com